GWS
CDMO

Glassman Wealth Services’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Glassman Wealth Services’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-132
Closed -$858 – 1924
2023
Q4 		$858 Buy
+132
New +$851 ﹤0.01% 1588
2015
Q1 		– Sell
-29
Closed – – 466
2014
Q4 		$0 Buy
+29
New +$292 ﹤0.01% 474

Other funds holding CDMO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Glassman Wealth Services's CDMO Position: Q1 2024 in Review

Glassman Wealth Services sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 132 shares — an estimated $858 sold.

Glassman Wealth Services first reported a position in CDMO in Q4 2014 and held it in 2 quarters. The position peaked at $858 in Q4 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Glassman Wealth Services reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 132 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $858.
  • Glassman Wealth Services first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2014 and held it in 2 quarters.
  • Glassman Wealth Services's Avid Bioservices, Inc. Common Stock position peaked at $858 in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.